Lipigon Pharmaceuticals AB (publ) (STO:LPGO)

CTI BioPharma Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.76	11.78	31.93	9.64	28.47	12.55
Cash & Short-Term Investments	3.76	11.78	31.93	9.64	28.47	12.55
Cash Growth	-84.32%	-63.12%	231.30%	-66.15%	126.81%	403.45%
Accounts Receivable	-	1.09	-	-	0.1	0.76
Other Receivables	1.09	0.96	1.25	0.97	0.49	0.27
Receivables	1.09	2.05	1.25	0.97	0.59	1.03
Prepaid Expenses	0.52	0.77	0.38	0.09	0.11	0.07
Other Current Assets	30.85	0	-	0.05	0.17	1.59
Total Current Assets	36.21	14.6	33.55	10.74	29.33	15.24
Property, Plant & Equipment	0.21	0.23	0.05	0.07	0.1	-
Total Assets	36.42	14.82	33.6	10.82	29.43	15.24
Accounts Payable	2.65	4.77	2.43	3.49	5.29	1.11
Accrued Expenses	1.96	2.05	1.77	3.35	1.07	1
Other Current Liabilities	2.56	0.24	0.96	0.11	0.11	0.15
Total Current Liabilities	7.17	7.06	5.16	6.95	6.47	2.26
Other Long-Term Liabilities	-	0	-0	-	-	-
Total Liabilities	7.17	7.06	5.16	6.95	6.47	2.26
Common Stock	0.59	0.59	14.25	2.28	1.1	0.53
Additional Paid-In Capital	131.59	131.59	127.55	102.82	85.39	34.86
Retained Earnings	-133.57	-124.41	-113.36	-101.23	-63.52	-22.41
Comprehensive Income & Other	30.64	-0	0	-	-	-
Shareholders' Equity	29.24	7.76	28.45	3.87	22.96	12.98
Total Liabilities & Equity	36.42	14.82	33.6	10.82	29.43	15.24
Net Cash (Debt)	3.76	11.78	31.93	9.64	28.47	12.55
Net Cash Growth	-84.32%	-63.12%	231.30%	-66.15%	126.81%	403.45%
Net Cash Per Share	0.02	0.09	0.50	0.66	3.16	2.84
Filing Date Shares Outstanding	148.33	148.33	126.42	20.24	9.73	4.73
Total Common Shares Outstanding	148.33	148.33	126.42	20.24	9.73	4.73
Working Capital	29.04	7.54	28.4	3.8	22.87	12.98
Book Value Per Share	0.20	0.05	0.22	0.19	2.36	2.74
Tangible Book Value	29.24	7.76	28.45	3.87	22.96	12.98
Tangible Book Value Per Share	0.20	0.05	0.22	0.19	2.36	2.74
Machinery	-	0.36	0.12	0.12	0.12	-

Updated Nov 21, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.